ModernMedicine Resource Center More Topics

Video

Featuring Dr. Meredith Overholt.

Actinic Keratoses - Evaluation & Management

Short ALA incubation coupled with blue light therapy yields effective, pain-free results.
Physicians have greatly changed the ways in which they use photodynamic therapy (PDT) since it was introduced, according to an expert who spoke at the South Beach Symposium recently.
Dermatologists and other medical specialists around the world who treat patients with actinic keratoses (AKs or solar keratoses) will soon be able to refer to new evidence-based (S3) guidelines for management.
Cryotherapy may be more effective than CO2 laser ablation in treatment of actinic keratosis (AKs) on the face and scalp, according to a recent study.
The commercialization of ingenol mebutate (Picato, LEO Pharma) a medication that is currently approved in the United States and many other countries for the treatment of actinic keratosis, is an example of how enthusiasm and commitment can drive innovation, a LEO Pharma general manager says.
At the MauiDerm 2014 meeting, conference organizer George Martin, M.D., shared five clinical pearls for treating facial actinic keratosis (AK).
A new study suggests that topical 5-fluorouracil (5-FU) may increase the risk of morpheaform basal cell carcinoma (mBCC) in patients with previous skin cancers.
Except in limited instances, an expert says, topical therapies for medical management of nonmelanoma skin cancers (NMSCs) work best as adjuncts to surgery.
New topical agents such as ingenol mebutate (Picato, Leo Pharma), reformulations of standing local treatments as well as combination therapies are not only proving to be very useful in the clearance of actinic keratosis (AK), but they also help address the common issues regarding field therapy.
A fractional resurfacing technique that uses a 1927 nm nonablative thulium laser reduces the number of facial actinic keratosis and provides noticeable clearance of photodamage, results of a recent study indicate.